Results 151 to 160 of about 1,093 (174)

Evaluating pitolisant as a narcolepsy treatment option

Expert Opinion on Pharmacotherapy, 2021
Gaia Pellitteri, Gian Luigi Gigli
exaly  

Pitolisant

Reactions Weekly, 2015
openaire   +1 more source

Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia

Journal of Clinical Psychopharmacology, 2020
Clément Dondé, Mircea Polosan, Rita Guzun   +2 more
openaire   +1 more source

Effects of pitolisant on nighttime sleep

Sleep Medicine, 2019
A. Triller, H. Hidalgo, U. Kallweit
openaire   +1 more source

Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model

Epilepsy and Behavior, 2013
Dorothea Kasteleijn-Nolst Trenité, Hirsch Edouard, Pascal Masnou   +2 more
exaly  

Methylphenidate/pitolisant/venlafaxine interaction

Reactions Weekly, 2020
openaire   +1 more source

Pitolisant for the treatment of narcolepsy with or without cataplexy.

Medizinische Monatsschrift fur Pharmazeuten, 2018
Since March 2016, a new treatment option for adult patients with narcolepsy – with or without cataplexy – has been granted marketing authorization in Europe. Pitolisant (Wakix®) is an inverse agonst at the histamine-3 (H3) receptor. In clinical studies, tests for measurement of wakefulness and attention, pitolisant showed significantly better results ...
openaire   +1 more source

<p>Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility</p>

Nature and Science of Sleep, 2020
Andrew Varga, David Rapoport, Robert Hiensch   +2 more
exaly  

The histamine H3-receptor inverse agonist Pitolisant improves fear memory in mice

Behavioural Brain Research, 2013
Ezio Tirelli
exaly  

Atomoxetine/pitolisant

Reactions Weekly
openaire   +1 more source